(Q44676500)

5 December 2017

title

Nebivolol/Hydrochlorothiazide : a new fixed-dose combination for effective simplified antihypertensive therapy (English)

1 reference

5 December 2017

Ettore Malacco

1

1 reference

5 December 2017

publication date

1 April 2008

1 reference

High Blood Pressure & Cardiovascular Prevention

5 December 2017

published in

1 reference

5 December 2017

volume

15

1 reference

5 December 2017

issue

2

1 reference

5 December 2017

page(s)

75-84

1 reference

https://scigraph.springernature.com/pub.10.2165/00151642-200815020-00006

5 December 2017

exact match

0 references

cites work

Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States

1 reference

12 December 2020

Blood pressure-dependent and independent effects of agents that inhibit the renin–angiotensin system

1 reference

12 December 2020

Global burden of hypertension: analysis of worldwide data

1 reference

12 December 2020

Re-examining the efficacy of beta-blockers for the treatment of hypertension: a meta-analysis

1 reference

12 December 2020

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

12 December 2020

Cardiovascular prevention and blood pressure reduction: a quantitative overview updated until 1 March 2003.

1 reference

12 December 2020

How strong is the evidence for use of beta-blockers as first-line therapy for hypertension? Systematic review and meta-analysis

1 reference

12 December 2020

Fixed dose combination therapy in the treatment of hypertension

1 reference

12 December 2020

Efficacy and safety of valsartan 160/HCTZ 25 mg in fixed combination in hypertensive patients not controlled by candesartan 32 mg plus HCTZ 25 mg in free combination

1 reference

12 December 2020

Tolerability, safety, and quality of life and hypertensive therapy: the case for low-dose diuretics

1 reference

12 December 2020

Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS).

1 reference

12 December 2020

Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group

1 reference

12 December 2020

Clinical pharmacodynamics of nebivolol: new evidence of nitric oxide-mediated vasodilating activity and peculiar haemodynamic properties in hypertensive patients

1 reference

12 December 2020

Nebivolol, bucindolol, metoprolol and carvedilol are devoid of intrinsic sympathomimetic activity in human myocardium

1 reference

12 December 2020

When antihypertensive monotherapy fails: fixed-dose combination therapy.

1 reference

12 December 2020

The 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy

1 reference

12 December 2020

A dose-response trial of nebivolol in essential hypertension.

1 reference

12 December 2020

Effects of metoprolol and carvedilol on pre-existing and new onset diabetes in patients with chronic heart failure: data from the Carvedilol Or Metoprolol European Trial (COMET).

1 reference

12 December 2020

Nebivolol decreases systemic oxidative stress in healthy volunteers

1 reference

12 December 2020

The significance of compliance and persistence in the treatment of diabetes, hypertension and dyslipidaemia: a review

1 reference

12 December 2020

Integrated effects of the vasodilating beta-blocker nebivolol on exercise performance, energy metabolism, cardiovascular and neurohormonal parameters in physically active patients with arterial hypertension

1 reference

12 December 2020

Nebivolol vs amlodipine as first-line treatment of essential arterial hypertension in the elderly

1 reference

12 December 2020

Angiotensin II antagonists for hypertension: are there differences in efficacy?

1 reference

12 December 2020

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

1 reference

12 December 2020

Influence of nebivolol and enalapril on metabolic parameters and arterial stiffness in hypertensive type 2 diabetic patients

1 reference

12 December 2020

Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo. Blunted response in essential hypertension.

1 reference

12 December 2020

2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension

1 reference

12 December 2020

Nebivolol in hypertension: a double-blind placebo-controlled multicenter study assessing its antihypertensive efficacy and impact on quality of life

1 reference

12 December 2020

Endothelial beta3-adrenoreceptors mediate nitric oxide-dependent vasorelaxation of coronary microvessels in response to the third-generation beta-blocker nebivolol.

1 reference

12 December 2020

beta Blockade after myocardial infarction: systematic review and meta regression analysis

1 reference

12 December 2020

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

1 reference

12 December 2020

New-onset diabetes and antihypertensive drugs

1 reference

12 December 2020

A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial

1 reference

12 December 2020

Comparative effects of nebivolol and atenolol on blood pressure and insulin sensitivity in hypertensive subjects with type II diabetes

1 reference

12 December 2020

Efficacy and tolerability profile of nebivolol vs atenolol in mild-to-moderate essential hypertension: results of a double-blind randomized multicentre trial

1 reference

12 December 2020

Efficacy of angiotensin-converting enzyme inhibitors and beta-blockers in the management of left ventricular systolic dysfunction according to race, gender, and diabetic status: a meta-analysis of major clinical trials

1 reference

12 December 2020

Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias

1 reference

12 December 2020

Comparative effects of a new cardioselective beta-blocker nebivolol and nifedipine sustained-release on 24-hour ambulatory blood pressure and plasma lipoproteins

1 reference

12 December 2020

Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension.

1 reference

12 December 2020

Effects of valsartan compared to amlodipine on preventing type 2 diabetes in high-risk hypertensive patients: the VALUE trial.

1 reference

12 December 2020

Effects of vasodilatory beta-adrenoceptor antagonists on endothelium-derived nitric oxide release in rat kidney

1 reference

12 December 2020

Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study

1 reference

12 December 2020

A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly.

1 reference

12 December 2020

Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party

1 reference

12 December 2020

Quality of life and antihypertensive effect with nebivolol and losartan

1 reference

12 December 2020

The vasodilator action of nebivolol in forearm vasculature of subjects with essential hypertension

1 reference

12 December 2020

Atenolol in hypertension: is it a wise choice?

1 reference

12 December 2020

Nebivolol: a review of its use in the management of hypertension and chronic heart failure

1 reference

12 December 2020

Angiotensin-Converting Enzyme Inhibitors and Calcium Channel Blockers for Coronary Heart Disease and Stroke Prevention

1 reference

12 December 2020

2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

1 reference

12 December 2020

Metabolic manifestations of low-dose diuretics

1 reference

12 December 2020

Effects of antihypertensive drug treatments on fracture outcomes: a meta-analysis of observational studies

1 reference

12 December 2020

Nebivolol reverses endothelial dysfunction in essential hypertension: a randomized, double-blind, crossover study.

1 reference

12 December 2020

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies

1 reference

12 December 2020

Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials

1 reference

12 December 2020

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

1 reference

12 December 2020

Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study).

1 reference

12 December 2020

Antihypertensive Drug Utilization in Hypertensive Veterans With Complex Medication Profiles

1 reference

12 December 2020

Effect of nebivolol and atenolol on brachial artery flow-mediated vasodilation in patients with coronary artery disease

1 reference

12 December 2020

Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials

1 reference

12 December 2020

Comparison of effects on systolic and diastolic left ventricular function of nebivolol versus atenolol in patients with uncomplicated essential hypertension

1 reference

12 December 2020

Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT).

1 reference

12 December 2020

Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials

1 reference

12 December 2020

Department of veterans Affairs single-drug therapy of hypertension study. Revised figures and new data. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents

1 reference

12 December 2020

Effect of nebivolol, a novel beta 1-selective adrenoceptor antagonist with vasodilating properties, on kidney function.

1 reference

12 December 2020

Systematic review: antihypertensive drug therapy in black patients

1 reference

12 December 2020

Effects of nebivolol and atenolol on insulin sensitivity and haemodynamics in hypertensive patients

1 reference

12 December 2020

Evaluation of the efficacy and tolerability of nebivolol versus lisinopril in the treatment of essential arterial hypertension: a randomized, multicentre, double-blind study

1 reference

12 December 2020

Hypertension prevalence, awareness, control and association with metabolic abnormalities in the San Marino population: the SMOOTH study

1 reference

12 December 2020

Nebivolol vasodilates human forearm vasculature: evidence for an L-arginine/NO-dependent mechanism

1 reference

12 December 2020

Metabolic profile of nebivolol, a beta-adrenoceptor antagonist with unique characteristics

1 reference

12 December 2020

Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis: principal results of the European Lacidipine Study on Atherosclerosis (ELSA), a randomized, double-blind, long-term trial

1 reference

12 December 2020

Comparative effects of nebivolol and metoprolol on oxidative stress, insulin resistance, plasma adiponectin and soluble P-selectin levels in hypertensive patients

1 reference

12 December 2020

Treatment of ambulatory hypertensives with nebivolol or hydrochlorothiazide alone and in combination. A randomized, double-blind, placebo-controlled, factorial-design trial

1 reference

12 December 2020

Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study

1 reference

12 December 2020

Efficacy and tolerability of nebivolol compared with other antihypertensive drugs: a meta-analysis

1 reference

12 December 2020

Relationship of office, home, and ambulatory blood pressure to blood glucose and lipid variables in the PAMELA population

1 reference

12 December 2020

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (A

1 reference

12 December 2020

Evidence-based interventions to improve patient compliance with antihypertensive and lipid-lowering medications

1 reference

12 December 2020

Risk stratification in hypertension: new insights from the Framingham Study

1 reference

12 December 2020

Adherence patterns among patients treated with fixed-dose combination versus separate antihypertensive agents

1 reference

12 December 2020

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

1 reference

12 December 2020

The cellular mechanisms involved in the vasodilator effect of nebivolol on the renal artery

1 reference

12 December 2020

Old antihypertensives and new diabetes

1 reference

12 December 2020

Cardiovascular mortality in hypertensive men according to presence of associated risk factors

1 reference

12 December 2020

Nebivolol decreases oxidative stress in essential hypertensive patients and increases nitric oxide by reducing its oxidative inactivation

1 reference

12 December 2020

Dispelling the myth of "aggressive" antihypertensive therapy

1 reference

12 December 2020

Patient compliance in hypertension: role of illness perceptions and treatment beliefs.

1 reference

12 December 2020

Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial

1 reference

12 December 2020

Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study

1 reference

12 December 2020

Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysis

1 reference

12 December 2020

10.2165/00151642-200815020-00006

Identifiers

DOI

1 reference

Dimensions Publication ID

5 December 2017

1012008254

0 references

1 reference